Bloomfield brings broad-based experience in commercial leadership roles with global corporations and proven business skills Strasbourg — Polyplus-transfection SA, the privately-held company developing innovative solutions for molecular and cellular biology, today announced that its board has appointed Mark Bloomfield as CEO. Mark Bloomfield replaces Frédéric Perraud who continues with Polyplus as COO and Deputy CEO. […]
Non-Animal Recombinant Proteins for Cell Culture & Tissue Engineering Applications AMSBIO has announced a new range of recombinant proteins that can substitute extracellular matrix proteins that are currently extracted from mouse sarcoma. The Mussel Adhesive Protein based matrix (MAPTrix®) ECM line of products are coating reagents with genetically incorporated bioactive peptides which mimic the extracellular […]
Pre-mixed, Optimized Set of Markers Provides Standardization, Consistency and Simplicity BREA, Calif. — Beckman Coulter, Inc. introduces Solastra, a comprehensive CE-marked panel of conjugated-antibody cocktails for the characterization of hematolymphoid neoplasia by flow cytometry. The pre-mixed and ready-to-use panels target the appropriate markers as recommended by the 2006 Bethesda International Consensus and are compatible with […]
ALAMEDA, Calif.–BioTime, Inc. (NYSE Amex: BTIM) announced earlier today that it plans to acquire ES Cell International Pte Ltd, a Singapore private limited company (“ESI”). In its press release earlier today, BioTime stated that it will “acquire all of ESI’s approximately $35 million of debt and accrued interest. ESI has no significant liabilities other than […]
GOLDEN, CO– Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced that it signed a contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix®, Inc., a leading firm known for its pioneering analysis of stem cells. HemoGenix® owns patented and patent-pending technology for analysis of stem cells known as the HALO® assay […]
TUCSON, Ariz.–HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™), today announced that Lee Hartwell, Ph.D., President & Director, Fred Hutchinson Cancer Research Center, 2001 Nobel Laureate, and Timothy Yeatman, M.D., Executive Vice President, Co-Founder & C.S.O. of M2Gen, have agreed to join HTG’s Scientific Advisory Board (SAB). “HTG’s technology is perfectly suited to […]
Project supported by a $250,000 economic development grant from the Kansas Bioscience Authority ST. LOUIS — SAFC®, a member of the Sigma-Aldrich® Group (Nasdaq: SIAL), today announced a $6.25 million investment program to expand its Lenexa, KS, facility and create a global ‘Center of Excellence’ for the seamless upstream and downstream production of dry powder […]
Madison, WI — Cellular Dynamics International, Inc. (CDI), already the world’s highest volume manufacturer of human heart cells, has closed on a $40.6 million Series B private equity round. This financing enables the company to increase production capacity for its iCellTM Cardiomyocytes, human heart cells derived from induced pluripotent stem cells (iPSCs), and to launch […]
A two-step ELISA that analyzes the quantity of ApoB in tissues, serum, plasma or cultured cells NewswireToday – /newswire/ – Austin, TX, United States — Today Bioo Scientific introduced a new MaxDiscovery™ Apolipoprotein B (ApoB) ELISA Kit, a complete, two-step ELISA that analyzes the quantity of ApoB in tissues, serum, plasma or cultured cells for […]
Eppendorf NA to market Akonni TruTip™ solutions for rapid, high-throughput nucleic acid extraction on epMotion® automated pipetting systems Hauppauge, NY & Frederick, MD — Eppendorf North America and Akonni Biosystems today announced they have entered into a joint marketing agreement to promote Akonni TruTip nucleic acid extraction kits configured for use with Eppendorf epMotion automated […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
